Navigation Links
Gabapentin Reduced Menopausal Symptoms as Estrogen – Study Find

n used off-label for years to treat headaches, shingles pain and other ailments. Scientists hypothesize that gabapentin may reduce hot flashes by regulating the flow of calcium in and out of cells, which is one mechanism for controlling body temperature.

An expert panel on menopause convened by the National Institutes of Health last year cautioned against the tendency to use treatments with scant safety data, and concluded that nothing to date was as effective as estrogen therapy although more research was needed.

In the latest study, Reddy and colleagues enrolled 60 women in a randomized, double-blind, placebo-controlled trial for 12 weeks. Initially the researchers received more than 1,500 calls from women who wanted to participate, but after screening the callers to meet the study's protocol, the number was whittled to 60, with 53 women complying with every step.

They were randomly divided into three groups: 20 women received gabapentin at 2,400 mg per day and a daily placebo or fake estrogen pill; 20 received estrogen in the form of Premarin at 0.625 mg per day and a fake gabapentin pill; 20 received sugar pills resembling gabapentin and estrogen. The women recorded the frequency and severity of their hot flashes in diaries.

Results were tabulated using two statistical methods to compare the women's hot flash reports throughout the 12-week period with their baseline symptoms. Doctors did find that women who took gabapentin complained more often of headaches, dizziness or disorientation. Researchers believe that slowly ramping up the medication and taking it with meals can alleviate the side effects.

Source: Eurekaert
'"/>




Page: 1 2

Related medicine news :

1. Reduced POD linked to fatal asthma attacks
2. Reduced fertility in men who mountain bike
3. Reduced Fatigue Boosts Mental Health
4. Rejection Rate for Liver Transplants Patient Reduced
5. Calcium-Vitamin D Combo For Reduced Fracture Risk
6. Heart Disease In Women Can Be Reduced By Eating Grapes
7. Cholesterol; Can Be Reduced By Sunflower Seeds, and Pistachios
8. Snoring To Be Reduced By New Device Called True Sleep
9. Infectious Diseases Reduced in China
10. Death Risk Of Ovarian Cancer Reduced By Intraperitoneal Chemotherapy
11. Breast Cancer Treatment Reduced From Six Weeks To Five Days.
Post Your Comments:
(Date:10/10/2008)...ewswire/ -- Do you think that the blind,can,t use ...nd the October,17 open house at the Virginia Rehab..., and see how instructors there empower the blind ...ng lives through non-visual,techniques taught at t...nue, is holding an open house to,celebrate the gra...
(Date:10/10/2008)...RNewswire/ -- NuView Life Sciences Inc.,(NuView) h...ces Inc.,(Trace), including operations of the line... in Denton, Texas. The Trace facility produces,Cop...llium-201 used in,molecular imaging and nuclear me...d that "We are confident that by improving operati...
(Date:10/10/2008)...artly to blame , , FRIDAY, Oct. 10 (Heal...s who have diabetes, being depressed was associate...dy. , Publishing in the October issue of the ...s from the University of Washington tracked 10,704...) who had diabetes and were enrolled in a disease ...
(Date:10/10/2008)... (NIH) scientists have identified a protein that p...od cells, T and B cells, enabling them to interact...ting immunity after an infection. Their finding m...netic defect that prevents them from making this p... a common virus that otherwise is rarely fatal (Ep...
Breaking Medicine News(10 mins):Health News:Virginia Rehabilitation Center for the Blind and Vision Impaired Celebrates Opening of New Student Dormitory 2Health News:Older Diabetics With Depression Face Higher Death Rate 2Health News:NIH scientists discover crucial control in long-lasting immunity 2Health News:NIH scientists discover crucial control in long-lasting immunity 3
...to a new study, patients with lung disease suffere...nhaled steroids. Researchers in Texas studied a gr...nary disease (COPD).// All received a high dose of...r a period of four months. After this time, they e...
...to a report, giving radiation to surgical treatmen...n the survival of patients. But the findings sugge...ery may help// improve the patient's quality of li...rrence at or near the original tumor site in the r...
...as invented and man learnt how to cook food. At fi...ety and a change from raw food, but today it domin...ste buds do appreciate raw food. Whether just to m...s or at home as a filler,no meal is complete witho...
...s in a study observed that human cytomegalovirus c...r. Although some people have a genetic predisposit...or no obvious reason.// Researchers at the Univers...link between viral infection and colon cancer. Fi...
Other Medicine News:Health News:Keep fit with salads 2Health News:Keep fit with salads 3
(Date:10/9/2008)...ted in November 2008, BOTHELL, Wash., Oct. 9 /PRN...DD ) announced today the completion of patient enr...tal trials to evaluate the safety and,efficacy of ...buprofen for,the over-the-counter (OTC) market. Th...this pivotal trial in November 2008. Ibuprofen is ...
(Date:10/8/2008)...wire-USNewswire/ -- The facts are,overwhelming. Ev...sub-Saharan Africa. More than 35,000,000 women, ch... died of AIDS. The Foundation for Hospices,in Sub-...their families,find compassion and relief from suf...nering initiative links African hospices and palli...
(Date:10/8/2008)...s Research That May Offer New Hope to,Heart Failur...nally, over 3,000 people are,waiting for a heart t...alf,of those will receive a transplant. Now, pione... paving the way for how to treat congestive heart,...ews Release, go to:, http://www.prnewswire.com/mnr...
(Date:10/8/2008)...e TAXUS(R) Element(TM) Platinum Chromium ... 8 /- Boston Scientific,Cor... completed enrollment in,the PERSEUS trial, design...S(R) Element(TM) paclitaxel-eluting coronary stent... 1,500 patients at 100 U.S. and,international cent...
Breaking Medicine Technology:SCOLR Pharma Announces Completion of Patient Enrollment and Dosing for Pivotal Clinical Trial Evaluating Extended Release Ibuprofen 2SCOLR Pharma Announces Completion of Patient Enrollment and Dosing for Pivotal Clinical Trial Evaluating Extended Release Ibuprofen 3In celebration of World Hospice and Palliative Care Day, FHSSA Announces Seven New Partnerships Between U.S. Organizations and African Hospices 2In celebration of World Hospice and Palliative Care Day, FHSSA Announces Seven New Partnerships Between U.S. Organizations and African Hospices 3In celebration of World Hospice and Palliative Care Day, FHSSA Announces Seven New Partnerships Between U.S. Organizations and African Hospices 4Video: Answer to Curing a Failing Heart May Exist in Body's Own 'Do-It-Yourself' Repair Kit 2Video: Answer to Curing a Failing Heart May Exist in Body's Own 'Do-It-Yourself' Repair Kit 3Boston Scientific Completes Clinical Trial Enrollment for Third-Generation Drug-Eluting Stent 2Boston Scientific Completes Clinical Trial Enrollment for Third-Generation Drug-Eluting Stent 3Boston Scientific Completes Clinical Trial Enrollment for Third-Generation Drug-Eluting Stent 4Sanofi aventis Announces a Good Third Quarter Performance 3B Increase in 2007 full year earnings growth guidance 5103 1Sanofi aventis Announces a Good Third Quarter Performance 3B Increase in 2007 full year earnings growth guidance 5103 2Sanofi aventis Announces a Good Third Quarter Performance 3B Increase in 2007 full year earnings growth guidance 5103 3Sanofi aventis Announces a Good Third Quarter Performance 3B Increase in 2007 full year earnings growth guidance 5103 4Sanofi aventis Announces a Good Third Quarter Performance 3B Increase in 2007 full year earnings growth guidance 5103 5Sanofi aventis Announces a Good Third Quarter Performance 3B Increase in 2007 full year earnings growth guidance 5103 6Sanofi aventis Announces a Good Third Quarter Performance 3B Increase in 2007 full year earnings growth guidance 5103 7Sanofi aventis Announces a Good Third Quarter Performance 3B Increase in 2007 full year earnings growth guidance 5103 8Sanofi aventis Announces a Good Third Quarter Performance 3B Increase in 2007 full year earnings growth guidance 5103 9Sanofi aventis Announces a Good Third Quarter Performance 3B Increase in 2007 full year earnings growth guidance 5103 10Sanofi aventis Announces a Good Third Quarter Performance 3B Increase in 2007 full year earnings growth guidance 5103 11Sanofi aventis Announces a Good Third Quarter Performance 3B Increase in 2007 full year earnings growth guidance 5103 12Sanofi aventis Announces a Good Third Quarter Performance 3B Increase in 2007 full year earnings growth guidance 5103 13Sanofi aventis Announces a Good Third Quarter Performance 3B Increase in 2007 full year earnings growth guidance 5103 14Sanofi aventis Announces a Good Third Quarter Performance 3B Increase in 2007 full year earnings growth guidance 5103 15Sanofi aventis Announces a Good Third Quarter Performance 3B Increase in 2007 full year earnings growth guidance 5103 16Sanofi aventis Announces a Good Third Quarter Performance 3B Increase in 2007 full year earnings growth guidance 5103 17Sanofi aventis Announces a Good Third Quarter Performance 3B Increase in 2007 full year earnings growth guidance 5103 18Sanofi aventis Announces a Good Third Quarter Performance 3B Increase in 2007 full year earnings growth guidance 5103 19Sanofi aventis Announces a Good Third Quarter Performance 3B Increase in 2007 full year earnings growth guidance 5103 20Sanofi aventis Announces a Good Third Quarter Performance 3B Increase in 2007 full year earnings growth guidance 5103 21Sanofi aventis Announces a Good Third Quarter Performance 3B Increase in 2007 full year earnings growth guidance 5103 22Sanofi aventis Announces a Good Third Quarter Performance 3B Increase in 2007 full year earnings growth guidance 5103 23Sanofi aventis Announces a Good Third Quarter Performance 3B Increase in 2007 full year earnings growth guidance 5103 24Sanofi aventis Announces a Good Third Quarter Performance 3B Increase in 2007 full year earnings growth guidance 5103 25Sanofi aventis Announces a Good Third Quarter Performance 3B Increase in 2007 full year earnings growth guidance 5103 26Sanofi aventis Announces a Good Third Quarter Performance 3B Increase in 2007 full year earnings growth guidance 5103 27Sanofi aventis Announces a Good Third Quarter Performance 3B Increase in 2007 full year earnings growth guidance 5103 28Sanofi aventis Announces a Good Third Quarter Performance 3B Increase in 2007 full year earnings growth guidance 5103 29Sanofi aventis Announces a Good Third Quarter Performance 3B Increase in 2007 full year earnings growth guidance 5103 30Sanofi aventis Announces a Good Third Quarter Performance 3B Increase in 2007 full year earnings growth guidance 5103 31Sanofi aventis Announces a Good Third Quarter Performance 3B Increase in 2007 full year earnings growth guidance 5103 32Sanofi aventis Announces a Good Third Quarter Performance 3B Increase in 2007 full year earnings growth guidance 5103 33Sanofi aventis Announces a Good Third Quarter Performance 3B Increase in 2007 full year earnings growth guidance 5103 34Sanofi aventis Announces a Good Third Quarter Performance 3B Increase in 2007 full year earnings growth guidance 5103 35Varian Inc Offers New Products for the Rapid Purification of Synthetic Oligonucleotides 5098 1Varian Inc Offers New Products for the Rapid Purification of Synthetic Oligonucleotides 5098 2Childrens gardens mushrooming 1053 1Childrens gardens mushrooming 1053 2Caesarean births pose higher risks for mother and baby 5096 1Caesarean births pose higher risks for mother and baby 5096 2
... July 3, 2007-- – The appearance of a,rash i... is,strongly associated with longer survival, acco...er, OSI Pharmaceuticals, Inc. This is,not the firs...al,advantage with EGFR inhibitors – a class ...tumumab and others designed to,block overproductio...
... July 3, 2007-- Ongoing therapeutic cancer vaccine...ring a,patient’s immune system to shrink tum...trials tend to live longer and respond,better to s...al,Cancer Research, a journal of the American Asso...ncer Institute researchers asks a,fundamental ques...
Other Medicine Technology:Skin Rash Actually Signifies Better Outcomes for Pancreatic and,Lung Cancer Patients 2Skin Rash Actually Signifies Better Outcomes for Pancreatic and,Lung Cancer Patients 3Skin Rash Actually Signifies Better Outcomes for Pancreatic and,Lung Cancer Patients 4From Clinical Cancer Research: Rethinking Therapeutic Cancer,Vaccine Trials 2From Clinical Cancer Research: Rethinking Therapeutic Cancer,Vaccine Trials 3
Triad Plus Skin Protectant Swabsticks prepare the skin for maximum adhesion of a dressing or bandage. When dry, they leave a thin film on the skin's surface. This provides a clean surface and a barri
BD Persist Plus protective barrier provides a one-step antimicrobial barrier with minimum of 1% chlorhexidine with Up to 7-day antimicrobial effectiveness.
BETADINE® Solution Swabsticks are indicated whenever a topical microbicide is applied most conveniently with a swabstick.
BD Persist contains 70% alcohol and 10% povidone iodine formulated in a unique polymer base, forming a barrier on the skin. The barrier creates a protective environment for the povidone iodin
Medicine Products: